TOP STORIES

• ACADEMIA Interview on SGLT-2 Inhibitor Use (2): Prof. Watada Calls for Caution in Analyzing EPPV Data
  March 9, 2015

• ACADEMIA Interview on SGLT-2 Inhibitor Use (1): Prof. Ueki Says Flat Sales Reflect Cautious Prescribing by Physicians
  March 6, 2015

• BUSINESS Pfizer Japan Sales Down 5% as Generic Erosion Weighs
  March 5, 2015

• BUSINESS Weber to Become CEO of Takeda in April
  March 4, 2015

• REGULATORY Pharma Might Skirt Market-Price Based Price Cuts in 2017 If Physician Fees Become Taxable
  March 3, 2015

• BUSINESS Eli Lilly Aims to Lead Japan Diabetes Market by 2020
  March 2, 2015

• REGULATORY Novartis Slapped with 15 Day Biz Suspension over Flawed ADR Reporting
  February 27, 2015

• ACADEMIA Govt-Backed Research Center Looks to License Malaria Vaccine to Mega Pharma
  February 27, 2015

• REGULATORY MHLW OKs 60 New APIs in 2014, Doubling from Year Ago
  February 26, 2015

• BUSINESS Takeda to Acquire Turkish Firm for Up to 14.5 Billion Yen, Earn 13 Branded Generics
  February 25, 2015

• BUSINESS Daiichi Sankyo to Shake Up Japan Organization as Olmetec Patent Expiry Nears
  February 25, 2015

• REGULATORY Shelved Decision on Xarelto Recommendation Doesn’t Mean Disapproval: MHLW
  February 24, 2015

• BUSINESS Sun Pharma Wins Japan Approval for Cravit Generics, Competition with Daiichi Sankyo Might Arise
  February 23, 2015

• REGULATORY Gilead’s Sofosbuvir Could Join NHI Price List in May If OK’ed by PAFSC Panel on March 5
  February 20, 2015

• REGULATORY Chuikyo Approves 26 Products Including Takecab, Zelboraf for Listing
  February 19, 2015

• BUSINESS Edoxaban Can Cover 80% of NOAC-Targeted Patients despite Restricted Use: US Commercial Chief
  February 18, 2015

• REGULATORY Abe Calls for Shrewd Strategies for Pharmas, Industry Consolidation as Necessary
  February 18, 2015

• BUSINESS Nichi-Iko to Exclusively Market Plavix Authorized Generics
  February 17, 2015

• BUSINESS Otsuka Holdings Weighs Staff Realignment as Abilify Patent Expiry Looms
  February 16, 2015

• BUSINESS GSK Eyes Transfer of Oncology Teams to Novartis from March
  February 13, 2015

ページ

• « 先頭
• ‹ Prev
• …
• 186
• 187
• 188
• 189
• 190
• 191
• 192
• 193
• 194
• …
• Next ›
• 最終 »